122 related articles for article (PubMed ID: 17644739)
1. RNA fingerprints provide direct evidence for the inhibitory role of TGFbeta and PD-1 on CD4+ T cells in Hodgkin lymphoma.
Chemnitz JM; Eggle D; Driesen J; Classen S; Riley JL; Debey-Pascher S; Beyer M; Popov A; Zander T; Schultze JL
Blood; 2007 Nov; 110(9):3226-33. PubMed ID: 17644739
[TBL] [Abstract][Full Text] [Related]
2. PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma.
Yamamoto R; Nishikori M; Kitawaki T; Sakai T; Hishizawa M; Tashima M; Kondo T; Ohmori K; Kurata M; Hayashi T; Uchiyama T
Blood; 2008 Mar; 111(6):3220-4. PubMed ID: 18203952
[TBL] [Abstract][Full Text] [Related]
3. Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival.
Muenst S; Hoeller S; Dirnhofer S; Tzankov A
Hum Pathol; 2009 Dec; 40(12):1715-22. PubMed ID: 19695683
[TBL] [Abstract][Full Text] [Related]
4. Imbalances of chemokines, chemokine receptors and cytokines in Hodgkin lymphoma: classical Hodgkin lymphoma vs. Hodgkin-like ATLL.
Ohshima K; Karube K; Hamasaki M; Suefuji H; Tutiya T; Yamaguchi T; Suzumiya J; Kikuchi M
Int J Cancer; 2003 Sep; 106(5):706-12. PubMed ID: 12866030
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotyping of the PD-L1-positive cells in angioimmunoblastic T cell lymphoma and Hodgkin disease.
Tiemann M; Samoilova V; Atiakshin D; Buchwalow I
BMC Res Notes; 2020 Mar; 13(1):139. PubMed ID: 32143684
[TBL] [Abstract][Full Text] [Related]
6. Augmented expression of programmed death-1 in both neoplastic and non-neoplastic CD4+ T-cells in adult T-cell leukemia/lymphoma.
Shimauchi T; Kabashima K; Nakashima D; Sugita K; Yamada Y; Hino R; Tokura Y
Int J Cancer; 2007 Dec; 121(12):2585-90. PubMed ID: 17721918
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometry CD4(+)CD26(-)CD38(+) lymphocyte subset in the microenvironment of Hodgkin lymphoma-affected lymph nodes.
Di Gaetano R; Gasparetto V; Padoan A; Callegari B; Candiotto L; Sanzari MC; Scapinello A; Tagariello G
Ann Hematol; 2014 Aug; 93(8):1319-26. PubMed ID: 24627194
[TBL] [Abstract][Full Text] [Related]
8. INFα-2b inhibitory effects on CD4(+)CD25(+)FOXP3(+) regulatory T cells in the tumor microenvironment of C57BL/6 J mice with melanoma xenografts.
Yu Y; Huang R; Zong X; He X; Mo W
BMC Cancer; 2016 Jul; 16():397. PubMed ID: 27389040
[TBL] [Abstract][Full Text] [Related]
9. Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma.
Aoki T; Chong LC; Takata K; Milne K; Hav M; Colombo A; Chavez EA; Nissen M; Wang X; Miyata-Takata T; Lam V; Viganò E; Woolcock BW; Telenius A; Li MY; Healy S; Ghesquiere C; Kos D; Goodyear T; Veldman J; Zhang AW; Kim J; Saberi S; Ding J; Farinha P; Weng AP; Savage KJ; Scott DW; Krystal G; Nelson BH; Mottok A; Merchant A; Shah SP; Steidl C
Cancer Discov; 2020 Mar; 10(3):406-421. PubMed ID: 31857391
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta inhibits human antigen-specific CD4+ T cell proliferation without modulating the cytokine response.
Tiemessen MM; Kunzmann S; Schmidt-Weber CB; Garssen J; Bruijnzeel-Koomen CA; Knol EF; van Hoffen E
Int Immunol; 2003 Dec; 15(12):1495-504. PubMed ID: 14645158
[TBL] [Abstract][Full Text] [Related]
11. Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma.
Tiacci E; Döring C; Brune V; van Noesel CJ; Klapper W; Mechtersheimer G; Falini B; Küppers R; Hansmann ML
Blood; 2012 Nov; 120(23):4609-20. PubMed ID: 22955914
[TBL] [Abstract][Full Text] [Related]
12. Complex Immune Evasion Strategies in Classical Hodgkin Lymphoma.
Wein F; Weniger MA; Höing B; Arnolds J; Hüttmann A; Hansmann ML; Hartmann S; Küppers R
Cancer Immunol Res; 2017 Dec; 5(12):1122-1132. PubMed ID: 29070649
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma.
Yang ZZ; Novak AJ; Stenson MJ; Witzig TE; Ansell SM
Blood; 2006 May; 107(9):3639-46. PubMed ID: 16403912
[TBL] [Abstract][Full Text] [Related]
14. Programmed death-1 (PD-1), programmed death-ligand 1 (PD-L1), and EBV-encoded RNA (EBER) expression in Hodgkin lymphoma.
Paydas S; Bağır E; Seydaoglu G; Ercolak V; Ergin M
Ann Hematol; 2015 Sep; 94(9):1545-52. PubMed ID: 26004934
[TBL] [Abstract][Full Text] [Related]
15. Non-conventional Inhibitory CD4
Zappasodi R; Budhu S; Hellmann MD; Postow MA; Senbabaoglu Y; Manne S; Gasmi B; Liu C; Zhong H; Li Y; Huang AC; Hirschhorn-Cymerman D; Panageas KS; Wherry EJ; Merghoub T; Wolchok JD
Cancer Cell; 2018 Jun; 33(6):1017-1032.e7. PubMed ID: 29894689
[TBL] [Abstract][Full Text] [Related]
16. Challenges and perspectives in the immunotherapy of Hodgkin lymphoma.
Michot JM; Lazarovici J; Ghez D; Danu A; Fermé C; Bigorgne A; Ribrag V; Marabelle A; Aspeslagh S
Eur J Cancer; 2017 Nov; 85():67-77. PubMed ID: 28892775
[TBL] [Abstract][Full Text] [Related]
17. Checkpoint Inhibition: Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors in Hodgkin Lymphoma.
Villasboas JC; Ansell S
Cancer J; 2016; 22(1):17-22. PubMed ID: 26841012
[TBL] [Abstract][Full Text] [Related]
18. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
[TBL] [Abstract][Full Text] [Related]
19. CXCR5 and ICOS expression identifies a CD8 T-cell subset with T
Le KS; Amé-Thomas P; Tarte K; Gondois-Rey F; Granjeaud S; Orlanducci F; Foucher ED; Broussais F; Bouabdallah R; Fest T; Leroux D; Yadavilli S; Mayes PA; Xerri L; Olive D
Blood Adv; 2018 Aug; 2(15):1889-1900. PubMed ID: 30087107
[TBL] [Abstract][Full Text] [Related]
20. Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL.
Vari F; Arpon D; Keane C; Hertzberg MS; Talaulikar D; Jain S; Cui Q; Han E; Tobin J; Bird R; Cross D; Hernandez A; Gould C; Birch S; Gandhi MK
Blood; 2018 Apr; 131(16):1809-1819. PubMed ID: 29449276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
